Butterfly Network, Inc. (BFLY) is a publicly traded Healthcare sector company. As of May 19, 2026, BFLY trades at $4.12 with a market cap of $1.00B and a P/E ratio of -12.20. BFLY moved +7.94% today. Year to date, BFLY is +2.40%; over the trailing twelve months it is +63.40%. Its 52-week range spans $1.32 to $5.72. Analyst consensus is strong buy with an average price target of $5.75. Rallies surfaces BFLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ventripoint Targets China’s 330M Patients with NMPA Green Channel Submission: On April 28, Ventripoint Diagnostics’ partner submitted its VMS+ 4.0 cardiac AI system to China’s NMPA green channel, targeting access to 330 million cardiovascular patients. Concurrently the company exhibited at AEPC in Padua and secured an Edison Award, Northern California hospital deal and Nisg̱a'a partnership.
| Metric | Value |
|---|---|
| Price | $4.12 |
| Market Cap | $1.00B |
| P/E Ratio | -12.20 |
| EPS | $-0.31 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.72 |
| 52-Week Low | $1.32 |
| Volume | 3.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $97.61M |
| Net Income | $-77.06M |
| Gross Margin | 46.85% |
4 analysts cover BFLY: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.75.